Cover Image

Alzheimer's disease advances in genetics, molecular, and cellular biology /

Alzheimer's Disease: Advances in Genetics, Cellular and Molecular Biology provides exciting, comprehensive and up-to-date summaries of the most important recent advances in the genetic, molecular, biochemical, and cell biological studies of AD. The studies and advances described in this volume...

Full description

Other Authors: Sisodia, Sangram S., Tanzi, Rudolph E., SpringerLink (Online service)
Format: eBook
Language: English
Published: New York : Springer, [2007]
Physical Description: 1 online resource (ix, 286 pages) : illustrations (some color)
Subjects:
LEADER 07124cam a2200793Ia 4500
001 184984798
003 OCoLC
005 20161107013858.9
006 m o d
007 cr cn|||||||||
008 071221s2007 nyua ob 001 0 eng d
019 |a 156929269  |a 228376914  |a 317881508  |a 607320392  |a 648133278  |a 698453934  |a 704438362  |a 756424932  |a 814476854 
020 |a 9780387351353 
020 |a 0387351353 
020 |a 9780387351346  |q (alk. paper) 
020 |a 0387351345  |q (alk. paper) 
035 |a (OCoLC)184984798  |z (OCoLC)156929269  |z (OCoLC)228376914  |z (OCoLC)317881508  |z (OCoLC)607320392  |z (OCoLC)648133278  |z (OCoLC)698453934  |z (OCoLC)704438362  |z (OCoLC)756424932  |z (OCoLC)814476854 
037 |a 978-0-387-35134-6  |b Springer  |n http://www.springerlink.com 
040 |a GW5XE  |b eng  |e pn  |c GW5XE  |d GW5XE  |d YDXCP  |d TEX  |d OCLCQ  |d DAY  |d EBLCP  |d N$T  |d CEF  |d UAB  |d E7B  |d UBC  |d IDEBK  |d OCLCQ  |d A7U  |d OCLCQ  |d OCLCF  |d BEDGE  |d OCLCQ  |d DEBSZ  |d OCLCQ  |d TXI  |d OCLCQ 
049 |a COM6 
050 4 |a RC523  |b .A3875 2007eb 
060 4 |a 2007 D-020 
060 4 |a WT 155  |b A47575 2007 
072 7 |a HEA  |x 039140  |2 bisacsh 
072 7 |a MED  |x 056000  |2 bisacsh 
082 0 4 |a 616.8/31  |2 22 
245 0 0 |a Alzheimer's disease :  |b advances in genetics, molecular, and cellular biology /  |c edited by Sangram S. Sisodia and Rudolph E. Tanzi. 
264 1 |a New York :  |b Springer,  |c [2007] 
264 4 |c ©2007. 
300 |a 1 online resource (ix, 286 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent. 
337 |a computer  |b c  |2 rdamedia. 
338 |a online resource  |b cr  |2 rdacarrier. 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a The Genetics of Alzheimer's Disease -- APP Biology, Processing and Function -- The Biology of the Presenilin Complexes --?-secretase: Physiological Role and Target Validation -- Cognitive Impairment in Transgenic A? and Tau Models of Alzheimer's Disease -- Cholesterol and?-Amyloid -- A? Structure and Aggregation -- Signaling Mechanisms that Mediate A? Induced Neuronal Dysfunction -- Beta Amyloid and Excitatory Synapses -- A? Degradation -- Role of A? Transport and Clearance in the Pathogenesis and Treatment of Alzheimer's Disease -- Tau Gene Mutations in FTDP-17 Syndromes -- Animal Models of Tauopathy -- Tau and Axonal Transport -- Growth Factors in Alzheimer's Disease. 
520 |a Alzheimer's Disease: Advances in Genetics, Cellular and Molecular Biology provides exciting, comprehensive and up-to-date summaries of the most important recent advances in the genetic, molecular, biochemical, and cell biological studies of AD. The studies and advances described in this volume will help to accelerate the process of rational drug discovery and soon serve to extend and enhance the mental health and lifespan of our burgeoning elderly population. In 1906, Dr. Alois Alzheimer presented the case of his patient, Auguste D., a 51 year-old female admitted to the local asylum who presented with early memory impairments, psychoses, hallucinations and morbid jealousy. Dr. Alzheimer would argue that specific lesions that were present in and around neurons were responsible for dementia. In the ensuing decades, studies of the disorder that affected Auguste D., which would be named Alzheimer's disease (AD), were largely limited to descriptive neuropathological and psychological assessments of this disease, but with little understanding of the molecular and cellular mechanisms underlying neurodegeneration and dementia. This would change in the 1980s when the protein components of the major neuropathological hallmarks of the disease, senile plaques (and cerebral blood vessel amyloid) and neurofibrillary tangles were first determined. The identification of the -amyloid protein (A) and the microtubule-associated tau protein as the main components of plaques and tangles, respectively, would pave the way for the molecular genetic era of AD research. By the late-1980s, the genes encoding the -amyloid precursor protein (APP) and tau (MAPT) were identified and would subsequently be shown to harbor autosomal dominant mutations causing early-onset familial AD and frontal temporal dementia (FTD), respectively. In the early 1990s, the e4 variant of the apoliprotein E gene (APOE) would be found to be associated with increased risk for late-onset AD. APP mutations increased the generation and subsequent deposition of the neurotoxic peptide, A42, in brain while APOE-e4 affected aggregation of A into fibrils and its clearance from brain. In 1995, genes encoding presenilin 1 and 2 (PSEN1, PSEN2) were identified, and mutations in MAPT were linked to frontal temporal dementia. Thus, by 1995, the stage was set for molecular studies of age-related dementias with APP, presenilin 1 and 2, APOE, and tau playing the major roles. The vast majority of studies addressing the molecular mechanisms underlying dementia would continue to focus on characterizing the five genes already firmly implicated in the etiology and pathogenesis of these dementing disorders, and these efforts have provided a firm foundation for translational studies that will hopefully serve to take these findings from the bench top to the bedside designing and developing novel ways to diagnose, treat, and prevent these diseases. 
650 0 |a Alzheimer's disease  |x Molecular aspects. 
650 0 |a Alzheimer's disease  |x Genetic aspects. 
650 0 |a Alzheimer's disease  |x Pathophysiology. 
650 1 2 |a Alzheimer Disease  |x physiopathology. 
650 0 |a Medicine. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Alzheimer's & Dementia.  |2 bisacsh. 
650 7 |a MEDICAL  |x Neurology.  |2 bisacsh. 
650 7 |a Biomédecine.  |2 eclas. 
650 7 |a Sciences de la vie.  |2 eclas. 
650 7 |a Alzheimer's disease  |x Genetic aspects.  |2 fast. 
650 7 |a Alzheimer's disease  |x Molecular aspects.  |2 fast. 
650 7 |a Alzheimer's disease  |x Pathophysiology.  |2 fast. 
655 4 |a Electronic books. 
700 1 |a Sisodia, Sangram S. 
700 1 |a Tanzi, Rudolph E. 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Print version:  |t Alzheimer's disease.  |d New York : Springer, ©2007  |z 9780387351346  |z 0387351345  |w (DLC) 2006926955  |w (OCoLC)85851366. 
907 |a .b29483876  |b multi  |c -  |d 100215  |e 191205 
998 |a cue  |a cu  |b 161129  |c m  |d z   |e -  |f eng  |g nyu  |h 0  |i 2 
948 |a MARCIVE Comp, Dec 2019 
948 |a MARCIVE Comp, May 22, 2018 
948 |a MARCIVE August, 2017 
948 |a MARCIVE extract Aug 5, 2017 
994 |a 92  |b COM 
995 |a Loaded with m2btab.ltiac in this month 
995 |a Loaded with m2btab.ltiac in 2018.06 
995 |a Loaded with m2btab.ltiac in 2017.08 
995 |a Loaded with m2btab.elec in 2016 
995 |a Loaded with m2btab.elec in 2016 
995 |a Loaded with m2btab.elec in 2016 
995 |a OCLC offline update by CMU 
989 |d cueme  |e  - -   |f  - -   |g j   |h 0  |i 0  |j 188  |k 161129  |l $0.00  |m    |n  - -   |o -  |p 0  |q 0  |t 0  |x 0  |w SpringerLink  |1 .i107180698  |u http://ezproxy.coloradomesa.edu/login?url=http://link.springer.com/10.1007/978-0-387-35135-3  |3 SpringerLink  |z Click here for access